Psychedelics and virtual reality: parallels and applications
Open accessAbstract
Psychedelic drugs and virtual reality (VR) each have the capacity to disrupt the rigidity and limitations of typical conscious experience. This article delineates the parallels among psychedelic and VR states as well as their potential synergistic applications in clinical and recreational settings. Findings indicate that, individually, psychedelics and VR are used in analogous ways to alter sensory experience and evoke awe. They are also both used in tandem with traditional therapies to treat a variety of mood disorders; their shared capacity to transiently alter perspective and disrupt rigid patterns of mental experience may underly their analogous and transdiagnostic therapeutic uses. In terms of their combined applications, a number of recreational users currently utilize psychedelics and VR together to enhance their experience. We propose that VR may be a useful tool for preparing hallucinogen-naïve participants in clinical trials for the sensory distortions experienced in psychedelic states. Given the critical role of "setting" in psychedelic treatment outcomes, we also detail how VR could be used to optimize the environment in psychedelic sessions. Finally, we provide considerations for future studies and detail how advancements in psychedelic and VR research can inform one another. Collectively, this article outlines a number of connections between psychedelics and VR, and, more broadly, is representative of growing scientific interest into the interactions among technology, psychopharmacology, and mental health.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both VR and psychedelic strategies may produce a synergic effect in patients with a specific psychiatric disorder if they receive an early treatment.
“In this sense, both strategies may produce a synergic effect in patients with a specific psychiatric disorder if they receive an early treatment (Aday, Davoli, & Bloesch, 2020).”
From Virtual reality and psychedelics for the treatment of psychiatric disease: A systematic literature review (2020) · cites this paper as Aday, Davoli, & Bloesch, 2020
The Parallels section says psychedelics and VR may improve some therapeutic treatments, but explicitly says further research is needed to determine whether combining them yields additive effects. The Combined applications section proposes possible therapeutic uses together. Neither section supports the claim's condition that patients receive early treatment, or establishes a synergistic effect for a specific psychiatric disorder. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90338-v · Cited by 7,153 · see citing works
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · see citing works
Virtual reality: Applications and implications for tourism
Guttentag, D. A. (2009) · Tourism Management · doi:10.1016/j.tourman.2009.07.003 · Cited by 1,833 · see citing works
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 2× · see citing works
“33 Given the potential for these intense emotional reactions, individuals with predispositions towards psychotic symptoms are generally excluded from current trials.”
BackgroundCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211 · see citing works
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · see citing works
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · see citing works
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970 · see citing works
Virtual reality exposure therapy for anxiety disorders: A meta-analysis
Powers, M. B., & Emmelkamp, P. M. G. (2008) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2007.04.006 · Cited by 904 · see citing works
Carl, E., Stein, A. T., Levihn-Coon, A., Pogue, J. R., Rothbaum, B., Emmelkamp, P., Asmundson, G. J. G., Carlbring, P., & Powers, M. B. (2019) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.08.003 · Cited by 889 · see citing works
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · see citing works
Awe Expands People’s Perception of Time, Alters Decision Making, and Enhances Well-Being
Rudd, M., Vohs, K. D., & Aaker, J. L. (2012) · Psychological Science · doi:10.1177/0956797612438731 · Cited by 744 · see citing works
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · see citing works
Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis
Opriş, D., Pintea, S., García-Palacios, A., Botella, C., Szamosközi, Ş., & David, D. (2012) · Depression and Anxiety · doi:10.1002/da.20910 · Cited by 636 · see citing works
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587 · see citing works
Carbonaro, T. M., Bradstreet, M. P., Barrett, F., Maclean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116662634 · Cited by 494 · see citing works
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488 · see citing works
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · see citing works
Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456 · see citing works
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 431 · see citing works
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · see citing works
Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59282-y · Cited by 375 · see citing works
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · see citing works
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.012 · Cited by 354 · cited 1× · see citing works
“23 In addition, while psychedelics are non-toxic (i.e., do not damage mammalian organ systems) 48 and have low potential for abuse, 49 the drugs are not risk-free as they can lead to psychologically challenging experiences for some individuals.”
BackgroundEffectiveness of Immersive Videos in Inducing Awe: An Experimental Study
Chirico, A., Cipresso, P., Yaden, D. B., Biassoni, F., Riva, G., & Gaggioli, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01242-0 · Cited by 343 · see citing works
Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin
Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2015) · Human Brain Mapping · doi:10.1002/hbm.22833 · Cited by 339 · see citing works
Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313 · see citing works
Embodying self-compassion within virtual reality and its effects on patients with depression
Falconer, C. J., Rovira, A., King, J. A., Gilbert, P., Antley, A., Fearon, P., Ralph, N., Slater, M., & Brewin, C. R. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.002147 · Cited by 312 · see citing works
Self unbound: ego dissolution in psychedelic experience
Letheby, C., & Gerrans, P. (2017) · Neuroscience of Consciousness · doi:10.1093/nc/nix016 · Cited by 293 · see citing works
Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780612 · Cited by 285 · see citing works
Designing awe in virtual reality: an experimental study
Chirico, A., Ferrise, F., Cordella, L., & Gaggioli, A. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02351 · Cited by 276 · see citing works
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3579-0 · Cited by 266 · see citing works
Human psychopharmacology of N,N-dimethyltryptamine
Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261 · see citing works
Long-term effects of psychedelic drugs: A systematic review
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.017 · Cited by 257 · see citing works
Self-citationClassical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256 · see citing works
Virtual reality exposure in the treatment of panic disorder and agoraphobia: A controlled study
Botella, C., García‐Palacios, A., Villa, H., Baños, R. M., Quero, S., Alcañiz, M., & Riva, G. (2007) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.524 · Cited by 242 · see citing works
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230 · see citing works
Game-based digital interventions for depression therapy: a systematic review and meta-analysis
Li, J., Theng, Y.-L., & Foo, S. (2014) · Cyberpsychology, Behavior, and Social Networking · doi:10.1089/cyber.2013.0481 · Cited by 219 · cited 1× · see citing works
“Li and colleagues reviewed the research on VR therapy for depression and found an average Cohen’s d of 0.67, 59 but this average was derived from just two studies.”
BackgroundInfluentialVirtual Reality Cognitive Behavior Therapy for Public Speaking Anxiety: A Randomized Clinical Trial
Wallach, H. S., Safir, M. P., & Bar-Zvi, M. (2009) · Behavior Modification · doi:10.1177/0145445509331926 · Cited by 218 · see citing works
Uthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., Toennes, S. W., Riba, J., & Ramaekers, J. G. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4988-3 · Cited by 212 · see citing works
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Liechti, M. E., Dolder, P. C., & Schmid, Y. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4453-0 · Cited by 198 · see citing works
Verhagen, T., Feldberg, F., van den Hooff, B., Meents, S., & Merikivi, J. (2011) · Computers in Human Behavior · doi:10.1016/j.chb.2011.10.020 · Cited by 188 · see citing works
Lyons, T., & Carhart-Harris, R. L. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117748902 · Cited by 183 · see citing works
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Hendricks, P. S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1474185 · Cited by 178 · see citing works
Barker, S. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00536 · Cited by 177 · see citing works
Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S., Rodríguez-Franco, M. I., Feilding, A., Perez-Castillo, A., & Riba, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-05407-9 · Cited by 175 · see citing works
Are You Awed Yet? How Virtual Reality Gives Us Awe and Goose Bumps
Quesnel, D. T., & Riecke, B. E. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02158 · Cited by 158 · see citing works
Richards, W. A. (2015) · Columbia University Press eBooks · doi:10.7312/columbia/9780231174060.001.0001 · Cited by 149 · see citing works
Niki, K., Okamoto, Y., Maeda, I., Mori, I., Ishii, R., Matsuda, Y., Takagi, T., & Uejima, E. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0527 · Cited by 145 · see citing works
LYSERGIC ACID DIETHYLAMIDE (LSD-25)
Savage, C. (1952) · American Journal of Psychiatry · doi:10.1176/ajp.108.12.896 · Cited by 137 · see citing works
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Gillman, P. K. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01575.x · Cited by 135 · see citing works
A Deep-Dream Virtual Reality Platform for Studying Altered Perceptual Phenomenology
Suzuki, K., Roseboom, W., Schwartzman, D. J., & Seth, A. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-16316-2 · Cited by 112 · see citing works
Stroud, J., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D., Curran, H. V., & Carhart-Harris, R. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4754-y · Cited by 104 · see citing works
PTSD Elderly War Veterans: A Clinical Controlled Pilot Study
Gamito, P., Oliveira, J., Rosa, P., Morais, D., Duarte, N., Oliveira, S., & Saraiva, T. (2010) · Cyberpsychology, Behavior, and Social Networking · doi:10.1089/cyber.2009.0237 · Cited by 101 · see citing works
The internet as a cultural forum: Implications for research
Jensen, K. B., & Helles, R. (2011) · New Media & Society · doi:10.1177/1461444810373531 · Cited by 99 · see citing works
Fear of flying treatment methods: virtual reality exposure vs. cognitive behavioral therapy.
Krijn, M., Emmelkamp, P. M. G., Ólafsson, R. P., Bouwman, M., Gerwen, L. J. V., Spinhoven, P., Schuemie, M. J., & van der Mast, C. P. A. G. (2007) · PubMed · Cited by 98 · see citing works
Nunes, A. A., SANTOS, R. G. D., Osório, F. D. L., Sanches, R. F., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1188225 · Cited by 91 · see citing works
Anderson, C. L., Dixson, D. D., Monroy, M., & Keltner, D. J. (2019) · Journal of Personality · doi:10.1111/jopy.12524 · Cited by 91 · see citing works
Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.
Kometer, M., & Vollenweider, F. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_461 · Cited by 88 · see citing works
Lima da Cruz, R. V., Moulin, T. C., Petiz, L. L., & Leão, R. N. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00312 · Cited by 84 · see citing works
Using virtual reality to augment perception, enhance sensorimotor adaptation, and change our minds
Wright, W. G. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00056 · Cited by 82 · see citing works
Wilhelm, F. H., Pfaltz, M. C., Gross, J. J., Mauss, I. B., Kim, S. I., & Wiederhold, B. K. (2005) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-005-6383-1 · Cited by 81 · see citing works
Replication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G. M., & Elliott, M. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05279-z · Cited by 77 · see citing works
Louria, D. B. (1968) · New England Journal of Medicine · doi:10.1056/nejm196802222780806 · Cited by 68 · see citing works
Virtual reality therapy in anxiety disorders
Mitrousia, V., & Giotakos, O. (2016) · Psychiatriki · doi:10.22365/jpsych.2016.274.276 · Cited by 60 · see citing works
Gallimore, A. R., & Strassman, R. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00211 · Cited by 53 · see citing works
Virtual Reality for Obsessive-Compulsive Disorder: Past and the Future
Kim, K., Kim, C.-H., Kim, S.-Y., Roh, D., & Kim, S. I. (2009) · Psychiatry Investigation · doi:10.4306/pi.2009.6.3.115 · Cited by 49 · see citing works
Sacred Vine of Spirits: Ayahuasca
Metzner, R. (2005) · Cited by 40 · see citing works
LSD in Psychotherapy and Alcoholism
Abramson, H. A. (1966) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1966.20.3.415 · Cited by 36 · see citing works
Virtual Reality Cue Refusal Video Game for Alcohol and Cigarette Recovery Support: Summative Study
Metcalf, M., ROSSIE, K. M., Stokes, K., Tallman, C., & Tanner, B. (2018) · JMIR Serious Games · doi:10.2196/games.9231 · Cited by 31 · see citing works
2018: A watershed year for psychedelic science
Aday, J. S., Davoli, C. C., & Bloesch, E. K. (2019) · Drug Science Policy and Law · doi:10.1177/2050324519872284 · Cited by 30 · see citing works
Self-citationThe social trajectory of virtual reality: Substantive ethics in a world without constraints
Cranford, M. (1996) · Technology in Society · doi:10.1016/0160-791x(95)00023-k · Cited by 25 · see citing works
Sepeda, N. D., Clifton, J. M., Doyle, L. Y., Lancelotta, R., Griffiths, R. R., & Davis, A. K. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.033 · Cited by 24 · see citing works
Jay, M. (2019) · Yale University Press eBooks · doi:10.2307/j.ctvgc61q9 · Cited by 23 · see citing works
Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Cognitive Enhancement · doi:10.1007/s41465-019-00151-6 · Cited by 21 · see citing works
Self-citationBeyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20thCentury
Aday, J. S., Bloesch, E. K., & Davoli, C. C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1581961 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- [7]Chesher C. Colonizing virtual reality: construction of the discourse of virtual reality, 1984–1992. Cultronix 1994; 1: 15– 28.
- [55]Korolov M. The real risks of virtual reality. Risk Manag 2014; 61: 20– 24.
- [70]Li J Theng YL Foo S Game-based digital interventions for depression therapy: a systematic review and meta-analysis. Cyberpsychology, Behavior, and Social Networking 2014; 17: 519– 527. PMC4118698 24810933
- [75]Jamnik MR Lane DJ. The use of Reddit as an inexpensive source for high-quality data. Pract Assess Res Evaluation 2017; 22: 1– 10.
- [81]Jay M. Mescaline: a global history of the first psychedelic. New Haven, London: Yale University Press, 2019.
- [82]Ross M. Virtual reality’s new synesthetic possibilities. Telev New Media 2018; 21: 152747641880524.
Cited by
Sorted by citations
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224 · see citing works
Self-citationMeasures and modalities in restorative virtual natural environments: An integrative narrative review
Nukarinen, T., Rantala, J., Korpela, K., Browning, M. H. E. M., Istance, H. O., Surakka, V., & Raisamo, R. (2021) · Computers in Human Behavior · doi:10.1016/j.chb.2021.107008 · Cited by 93 · see citing works
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works
Chung, O. S., Robinson, T., Johnson, A. M., Dowling, N. L., Ng, C. H., Yücel, M., & Segrave, R. A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791123 · Cited by 51 · see citing works
Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics
Glowacki, D. R., Williams, R. R., Wonnacott, M., Maynard, O., Freire, R., Pike, J. E., & Chatziapostolou, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-12637-z · Cited by 56 · see citing works
Psychedelic-assisted psychotherapy: Where is the psychotherapy research
Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06620-x · Cited by 54 · see citing works
Self-citationThe Potential Role of Psychedelic Drugs in Mental Health Care of the Future
Gründer, G., & Jungaberle, H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1486-7386 · Cited by 39 · see citing works
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy
Sekula, A. D., Downey, L. A., & Puspanathan, P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.813746 · Cited by 27 · see citing works
Kaup, K., Vasser, M., Tulver, K., Munk, M., Pikamäe, J., & Aru, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1088896 · Cited by 26 · see citing works
Addressing blinding in classic psychedelic studies with innovative active placebos
Aday, J. S., Simonsson, O., Schindler, E. A. D., & D’Souza, D. C. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf023 · Cited by 26 · see citing works
Self-citationAcid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics
Tvorun‐Dunn, M. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103890 · Cited by 23 · see citing works
Cyberdelics in context: On the prospects and challenges of mind-manifesting technologies
Hartogsohn, I. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1073235 · Cited by 18 · see citing works
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A. L., McDonald, W. M., Widge, A. S., Rodríguez, C. I., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230682 · Cited by 16 · see citing works
Wang, C., Kong, J., & Qi, H. (2023) · Healthcare · doi:10.3390/healthcare11142056 · Cited by 15 · see citing works
Glowacki, D. R. (2024) · Frontiers in Virtual Reality · doi:10.3389/frvir.2023.1286950 · Cited by 14 · see citing works
Huang, Y., Deng, C., Peng, M., & Hao, Y. (2024) · BMC Palliative Care · doi:10.1186/s12904-024-01520-5 · Cited by 13 · see citing works
Gómez-Busto, F. J., & Ortiz, M. I. (2020) · PubMed Central · doi:10.36131/cnfioritieditore20200606 · Cited by 12 · see citing works
What should constitute a control condition in psychedelic drug trials?
Colloca, L., & D, M. F. M. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00321-2 · Cited by 12 · see citing works
Magni, G., Tuena, C., & Riva, G. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1219052 · Cited by 10 · see citing works
Casu, M., Farrauto, C., Farruggio, G., Bellissima, S., Battiato, S., & Caponnetto, P. (2024) · Psychology International · doi:10.3390/psycholint6020036 · Cited by 9 · see citing works
Cyberdelics: Virtual reality hallucinations modulate cognitive-affective processes
Brizzi, G., Pupillo, C., Rastelli, C., Greco, A., Bernardelli, L., Natale, A. F. D., Pizzoli, S. F. M., Sajno, E., Frisone, F., Lernia, D. D., et al. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2499459 · Cited by 10 · see citing works
Cyberdelics: Context engineering psychedelics for altered traits
Smith, C. H., & Warner, M. (2022) · Electronic workshops in computing · doi:10.14236/ewic/eva2022.48 · Cited by 7 · see citing works
Psychedelics, OCD and Related Disorders: Setting methodological strategies for future studies
Leuzzi, R., Tardivo, G., Pellegrini, L., Albert, U., & Fineberg, N. A. (2025) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2025.100951 · Cited by 5 · see citing works
Ciaunica, A., & Safron, A. (2022) · doi:10.31234/osf.io/mah78 · Cited by 5 · see citing works
Tudorancea, I.-M., Stanciu, G. D., Torrent, C., Madero, S., Hriţcu, L., & Tamba, B.-I. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2499458 · Cited by 4 · see citing works
AI-generated virtual psychedelics bridge digital and therapeutic frontiers in mental health research
Riva, G., Brizzi, G., Rastelli, C., & Greco, A. (2026) · Nature Mental Health · doi:10.1038/s44220-025-00576-3 · Cited by 3 · see citing works
How to set up a psychedelic study: Unique considerations for research involving human participants
Glennon, M. J., Bird, C., Yadav, P., Kleine, P., Suseelan, S., Boman-Markaki, C., Kotoula, V., Butler, M., Leech, R., Roseman, L., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106657 · Cited by 5 · see citing works
Exploring Peak Experiences through Multi-Sensory Extended Reality
Thaker, S., Heitmayer, M., & Hanley, T. (2025) · ACM International Conference on Interactive Media Experiences · doi:10.1145/3706370.3731932 · Cited by 3 · see citing works
Glowacki, D. R., Williams, R. R., Maynard, O., Pike, J. E., Freire, R., Wonnacott, M., & Chatziapostolou, M. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2105.07796 · Cited by 3 · see citing works
Stone, J., Baker, L., Altvater, R. A., & Ong, T. (2025) · Journal of Medical Extended Reality · doi:10.1177/29941520251394885 · Cited by 2 · see citing works
Lange, L., Yenney, J., & Wu, Y. C. (2025) · International Conference on Tangible, Embedded, and Embodied Interaction (TEI) · doi:10.1145/3689050.3705999 · Cited by 3 · see citing works
Chung, O. S., Robinson, T., Johnson, A. M., Dowling, N. L., Ng, C. H., Yücel, M., & Segrave, R. A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.893637 · Cited by 2 · see citing works
Increases in EEG Alpha Power and Beta Power Following a VR Psychedelic JourneyPreprint
Mattek, S. (2024) · doi:10.31234/osf.io/8b3wq · Cited by 2 · see citing works
Integrating Psychedelics into Digital Health: A New Horizon in Mental Wellness
Wiederhold, B. K. (2024) · Cyberpsychology Behavior and Social Networking · doi:10.1089/cyber.2024.34732 · Cited by 2 · see citing works
Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"
Jerotić, S., Čolović, O., & Marić, N. P. (2026) · Medicinska istrazivanja · doi:10.5937/medi0-62051 · Cited by 1 · see citing works
DİJİTAL TASARIMDA KULLANICI DENEYİMİ SUNAN PSİKEDELİK YAKLAŞIMLAR
Çakmak, B. (2022) · Sanat ve Tasarım Dergisi · doi:10.20488/sanattasarim.1133856 · Cited by 1 · see citing works
Dynamic VR Modulation with EEG Feedback for Psychedelic Simulation
Lange, L., Yenney, J., & Wu, Y. C. (2025) · IEEE Conference on Virtual Reality and 3D User Interfaces Abstracts and Workshops (VRW) · doi:10.1109/vrw66409.2025.00353 · Cited by 1 · see citing works
Ciaunica, A., & Safron, A. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192898371.003.0004 · Cited by 7 · see citing works
Huang, Y., Deng, C., Peng, M., & Yanping, H. (2024) · Figshare · doi:10.6084/m9.figshare.26752858
Huang, Y., Deng, C., Peng, M., & Yanping, H. (2024) · Figshare · doi:10.6084/m9.figshare.26752855
Huang, Y., Deng, C., Peng, M., & Yanping, H. (2024) · Figshare · doi:10.6084/m9.figshare.26752861
Mele, M. L., & Rutrecht, H. M. (2026) · Lecture notes in computer science · doi:10.1007/978-3-032-12808-9_8
Coaching mit künstlicher Intelligenz und Virtual Reality
Ulbrich, S., & García, T. (2026) · Springer eBooks · doi:10.1007/978-3-662-71516-1_43
Chordiya, P., Lange, L., & Wu, Y. C. (2025) · International IEEE/EMBS Conference on Neural Engineering · doi:10.1109/ner61569.2025.11589042
Hewitt, T., Seth, A. K., & Schwartzman, D. J. (2026) · Royal Society Open Science · doi:10.1098/rsos.260647
- Authors
- Aday, J. S., Davoli, C. C., & Bloesch, E. K.
- Affiliations
- Central Michigan University (US)
- Corresponding author
- Aday, Jacob S.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 10
- Pages
- 2045125320948356-2045125320948356
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC7446267
- OpenAlex
- W3049149550
- Cited by
- 47
- References
- 79
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 11 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 1
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- psychedelics, virtual reality, hallucinogens, mood disorders, transdiagnostic treatment, awe, setting effects, recreational use, mental health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
